Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Arthritis Rheumatol. 2019 May 29;71(8):1297–1307. doi: 10.1002/art.40859

Table 1 -.

Demographic and clinical characteristics of SLE patients in the SLICC inception cohort at the time of their baseline visit and last follow-up visit.

Variables Baseline visit (n = 1683) Last follow-up visit (n=1507)
Patient age (years)
 Mean (S.D.) 35.7 (13.4) 42.8 (13.6)
Sex
 Female, n (%) 1493 (88.7) 1337 (88.7)
 Male, n (%) 190 (11.3) 170 (11.3)
Race/Ethnicity
 Caucasian, n (%) 834 (49.6) 742 (49.2)
 African ancestry, n (%) 280 (16.6) 246 (16.3)
 Asian, n (%) 260 (15.5) 245 (16.3)
 Hispanic, n (%) 248 (14.7) 222 (14.7)
 Other, n (%) 61 (3.6) 52 (3.5)
Geographic location
 United States, n (%) 467 (27.7) 377 (25.0)
 Canada, n (%) 395 (23.5) 376 (25.0)
 Mexico, n (%) 197 (11.7) 181 (12.0)
 Europe, n (%) 461 (27.4) 419 (27.8)
 Asia, n (%) 163 (9.7) 154 (10.2)
Education
 Post-secondary education, n (%) 847 (50.3) 767 (50.9)
 Missing, n (%) 22 (1.3) 20 (1.3)
SLE disease duration (years)
 Median (I.Q.R.) 1.2 (0.9–1.5) 8.5 (5.6 – 11.3)
SLEDAI-2K
 Median (I.Q.R.) 2 (0–6) 2 (0–4)
SLICC/ACR Damage Index (SDI)
 SDI = 0, n (%) 1270 (75.5) 721 (47.8)
SF-36 Physical Component Score (PCS)
 Median (I.Q.R.) 41.7 (32.5–50.8) 43.7 (32.6–52.6)
SF-36 Mental Component Score (MCS)
 Median (I.Q.R.) 48.8 (37.4–55.8) 49.8 (39.3–56.1)

Notes: S.D. = standard deviation; I.Q.R. = interquartile range; SLICC = Systemic Lupus International Collaborating Clinics; SLEDAI-2K = SLE disease activity index 2000; SF-36 = Short-Form 36